[Remote] Director, RWD Strategy Enablement at Bristol-Myers Squibb

United States

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Bachelor's degree required; Advanced degree preferred
Minimum of 7 years of relevant experience
Minimum of 2 years of in-depth knowledge of real-world healthcare data and use cases
Experience collaborating with data vendors/suppliers
Real-world data contracting experience is preferred
Understanding of data platform environments including cloud and hosted; 5+ years preferred
Experience managing budgets desired
Management consulting (strategy) experience; 2+ years preferred

Responsibilities

Have deep knowledge of the RWD ecosystem inside and external to BMS' platforms and collaborate with RWD researchers and vendors to understand uses, needs and problems with data assets and partners and enable broad use of RWD
Have a deep understanding of the compliance landscape (HIPAA, GDPR, contractual agreements, etc.) and provide training and consultative support to all RWD users on matters of data usage, privacy and access
Lead HYD-based RWDS Enablement team (dotted line) to fully support execution of contracts and related platforming and monitoring activities
Shape and lead the BMS RWD Enablement Council to advance RWD use and maintain transparency on RWD legal matters
Lead contracting and data onboarding for RWD across multiple enabling functions (BI&T, Legal, Strategic Sourcing +) on behalf of RWD users across BMS
Understand and administer SOP 3r (Real-world Data); track compliance and manage audits
Implement AI-enabled solutions across RWD Enablement business processes to improve effectiveness and efficiency of the capability
Partner with Data Products team to enable all appropriate security and training required by contracts; ensure data platforming conforms with relevant requirements globally; ensure data is de-platformed in accordance with contracts
Partner with RWD Strategy counterparts to manage the RWD budget and make recommendations on future contracting goals as business priorities change
Partner with BI&T and business stakeholders to maintain an up-to-date, searchable, metadata-driven data catalog, creating visibility and knowledge sharing about all RWD assets
Communicate effectively about RWD Enablement capabilities, results / updates, recommendations through written, oral and presentation formats
Lead data strategy business enablement work streams to meet business objectives
Educate business partners on compliant RWD use and organize training from data partners for RWD user community
Leverage AI and other tools to evolve Enablement processes
Support strategy engagement with data partners on RWD licensing and support all RWD contracting initiatives required by SOP

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free